2014 ICD-9-CM Diagnosis Code 237.72
Neurofibromatosis, type 2 [acoustic neurofibromatosis]
- Short description: Neurofibromatosis typ II.
- ICD-9-CM 237.72 will be replaced by an equivalent ICD-10-CM code (or codes) when the United States transitions from ICD-9-CM to ICD-10-CM on October 1, 2015.
- ICD-9-CM 237.72 is a billable medical code that can be used to specify a diagnosis on a reimbursement claim.
- Neurofibromatosis, type 2
- A genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow.
- An autosomal dominant disorder caused by mutations in the nf2 tumor suppressor gene. It is characterized by the development of peripheral and central nervous system tumors including acoustic schwannomas, neurofibromas, gliomas, and meningiomas.
- An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (neurilemmoma) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the nf2 gene (genes, neurofibromatosis 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
Convert to ICD-10-CM
converts directly to:
- 2014 ICD-10-CM Q85.02 Neurofibromatosis, type 2
ICD-9-CM Volume 2 Index
entries containing back-references to 237.72
- Neurofibroma (M9540/0) - see also Neoplasm, connective tissue, benign
- Neurofibromatosis (multiple) (M9540/1) 237.70
- acoustic 237.72
- type 2 237.72
- Neuroma (M9570/0) - see also Neoplasm, connective tissue, benign